Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203835 Screening for inotropic agents using fluorescence, absorption spectra, luminescence or radioactivity
10/30/2003US20030203833 Association of asthma with polymorphisms in the cysteinyl leukotriene 2 receptor
10/30/2003US20030203503 Method for measuring substance and testing piece
10/30/2003US20030203498 For sensing blood glucose levels electrochemically
10/30/2003US20030203497 Using bioassay to monitor combinatorial library synthesis and rank products in order of their ability to bind to a target molecule which is capable of unfolding when heated
10/30/2003US20030203486 Transfection method and uses related thereto
10/30/2003US20030203483 Differentiated mesenchymal cells for enhancing engraftment of hematopoietic progenitor cells, bone marrow transplantation or treatment and/or prevention of graft versus host disease
10/30/2003US20030203477 Bioreactor for use in isolation and propagation of microganisms in blood
10/30/2003US20030203469 Efficient purification of adenovirus
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203424 Which comprises octadecyl trimethyl ammonium iodide; for use with lake-sized public water supply reservoirs
10/30/2003US20030203422 Combining liquid water sample and a powdered medium having nutrient indicator; incubating the mixture for a time sufficient to produce a detectable color signal indicative of presence or absence of target microbe; observing signal
10/30/2003US20030203421 Stabilized tetrazolium reagent compositions and methods for using the same
10/30/2003US20030203420 Cytotoxicity assay
10/30/2003US20030203418 Animal models and methods for sepsis
10/30/2003US20030203416 ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
10/30/2003US20030203407 Compositions and methods for monitoring the phosphorylation of natural binding partners
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203399 Proportional amplification of nucleic acids
10/30/2003US20030203398 Ribosomal DNA sequence for detection of activated sludge bacterial strain; biodegradation; bioremediation
10/30/2003US20030203397 Diagnosing cancer via screening and identifying aberrations/polymorphisms in nucleotide sequences of tumor marker genes in biopsied tissues
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203395 TCF-1 nucleotide sequence variation
10/30/2003US20030203394 Detection of a target in a sample
10/30/2003US20030203393 Using fluorescence to characterize, screen and identify mitotic cell chromosomal aberration; cancer diagnosis
10/30/2003US20030203392 Detecting sterol regulatory element binding protein (SREBP) for use in the treatment of hyperlipemia, arteriosclerosis, obesity or cancer; drug screening
10/30/2003US20030203391 Contains urea denaturant which allows hybridization at lower temperature, for use with nucleic acids/biopolymers and microarrays; kits
10/30/2003US20030203389 Method for the 5'-cap-dependent amplification of cDNAs
10/30/2003US20030203388 Using mammalian cells to detect and monitor mutagenic agents 2
10/30/2003US20030203387 Determining whether test DNA molecule and reference nucleic acid share significant sequence homology
10/30/2003US20030203384 Multiplex detection of biological materials in a sample
10/30/2003US20030203382 Detecting the presence of nucleic acid sequence variants in a subpopulation of nucleic acid molecules in a biological sample ; useful for identifying individuals with mutations indicative of cancer
10/30/2003US20030203381 Single Nucleotide Polymorphism (SNP) testing, using two kinds of primers which are complementary to a mutant target and a wild-type target, and different in length or migration speed in electrophoresis
10/30/2003US20030203380 Gene linked to osteoarthritis
10/30/2003US20030203379 Method for analyzing biomolecule
10/30/2003US20030203378 Based on identification of species specific 5' hinge and 3' hinge regions of U3 small nucleolar ribonucleic acid (snoRNA)
10/30/2003US20030203376 Compositions, methods and kits for determining the presence of Mycoplasma genitalium in a test sample
10/30/2003US20030203374 Assaying cells in a biological sample to distinguish between living and dead cells
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203372 Analysis method
10/30/2003US20030203370 Method and system for partitioning sets of sequence groups with respect to a set of subsequence groups, useful for designing polymorphism-based typing assays
10/30/2003US20030203367 Novel nomenclature or use of specific digital assignments to the bases in the deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)
10/30/2003US20030203366 Microarray channel devices produced by a block mold process
10/30/2003US20030203364 By using a temperature gradient electrophoresis in the presence of a probe; for generating data indicative of the presence of a nucleotide polymorphism, mutation, or methylated cytosine in nucleotide containing compounds
10/30/2003US20030203362 Species specific identification of spore-producing microbes using the gene sequence of small acid-soluble spore coat proteins for amplification based diagnostics
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203360 Methods for identifying products employing gene expression
10/30/2003US20030203358 Depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined exogenous nucleic acid
10/30/2003US20030203357 Detecting and differentiating viruses or other intracellular parasites present in a specimen; compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents
10/30/2003US20030203355 Preparing such binding ligands and libraries, and methods of identifying a binding ligand that specifically binds to a target molecule
10/30/2003US20030203351 Comprised of a tissue block from adult tonsil or lymph node supported on a matrix which is flexible and porous and the supported tissue block is cultured in a medium whose surface is congruent with the tissue block/matrix interface
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202906 Adding the amperage of the conductive film of the biosensor
10/30/2003US20030202904 Method for analyzing blood test sample and dry analytical element and analytical kit utilizing the method
10/30/2003US20030201194 Quantitative analysis; redox systems; monitoring glucose concentration
10/30/2003US20030201177 Hemoglobin sensor
10/30/2003US20030200644 Electrochemical analyzing; multilayer laminated structure
10/30/2003CA2785889A1 Peptide inhibitors of protein kinase c
10/30/2003CA2484397A1 Methods for measuring protein kinase and phosphatase activity
10/30/2003CA2483338A1 Method of creating a library of bacterial clones with varying levels of gene expression
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482856A1 Plasma protein-binding ligands
10/30/2003CA2482769A1 "doping" in walk-through mutagenesis
10/30/2003CA2482767A1 Reagents for monitoring nuclei acid amplification and methods of using same
10/30/2003CA2482611A1 Functionalized nanoparticles and methods of use
10/30/2003CA2482529A1 Method for detecting ligands and targets in a mixture
10/30/2003CA2482485A1 Matrix analysis of gene expression in cells (magec)
10/30/2003CA2482481A1 Method to enhance homologous recombination
10/30/2003CA2482029A1 Peptide deformylase activated prodrugs
10/30/2003CA2481941A1 Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481548A1 Cytotoxicity assay
10/30/2003CA2481512A1 Peptide inhibitors of protein kinase c.gamma. for pain management
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481409A1 Thermostable dna polymerases and methods of making same
10/30/2003CA2481171A1 Hepatitis c virus assay systems
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2479501A1 Methods for screening for a compound useful in the treatment or prevention of lymphocytic disorders, for inhibiting lymphocyte activity and preventing or treating lymphocytic disorders
10/30/2003CA2475418A1 Mutation of dna polymerases from archaeobacteria
10/30/2003CA2461562A1 Methods for the electrochemical detection of multiple target compounds
10/29/2003EP1357383A1 High-density lipoprotein assay device and method
1 ... 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 ... 3003